Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma cells
about
An Epstein-Barr virus anti-apoptotic protein constitutively expressed in transformed cells and implicated in burkitt lymphomagenesis: the Wp/BHRF1 linkEpstein-Barr virus-induced genes: first lymphocyte-specific G protein-coupled peptide receptorsLatent membrane protein 2A of Epstein-Barr virus binds WW domain E3 protein-ubiquitin ligases that ubiquitinate B-cell tyrosine kinasesOncogenic role of Epstein-Barr virus-encoded RNAs in Burkitt's lymphoma cell line AkataExpression of Epstein-Barr virus nuclear antigen-1 induces B cell neoplasia in transgenic miceRecognition of the Epstein-Barr virus-encoded nuclear antigens EBNA-4 and EBNA-6 by HLA-A11-restricted cytotoxic T lymphocytes: implications for down-regulation of HLA-A11 in Burkitt lymphoma.Characterization of the Epstein-Barr virus-inducible gene encoding the human leukocyte adhesion and activation antigen BLAST-1 (CD48)Epstein-Barr virus and Burkitt lymphomaGamma-herpesvirus latency requires T cell evasion during episome maintenanceThe Role of Gammaherpesviruses in Cancer PathogenesisAdoptive T-Cell ImmunotherapyKeeping it quiet: chromatin control of gammaherpesvirus latencyEpstein-Barr virus LMP2A reduces hyperactivation induced by LMP1 to restore normal B cell phenotype in transgenic miceThe B-cell specific transcription factor, Oct-2, promotes Epstein-Barr virus latency by inhibiting the viral immediate-early protein, BZLF1Different Mechanisms of Regulation of the Warburg Effect in Lymphoblastoid and Burkitt Lymphoma CellsTransfection of the c-myc oncogene into normal Epstein-Barr virus-harboring B cells results in new phenotypic and functional features resembling those of Burkitt lymphoma cells and normal centroblastsHLA A2.1-restricted cytotoxic T cells recognizing a range of Epstein-Barr virus isolates through a defined epitope in latent membrane protein LMP2.CD34+ cord blood cell-transplanted Rag2-/- gamma(c)-/- mice as a model for Epstein-Barr virus infectionThe synthesis of truncated polypeptides for immune surveillance and viral evasion.EBV gene expression in an NPC-related tumour.Epstein-barr virus nuclear antigen 1 sequences in endemic and sporadic Burkitt's lymphoma reflect virus strains prevalent in different geographic areas.IL-21 imposes a type II EBV gene expression on type III and type I B cells by the repression of C- and activation of LMP-1-promoter.Inhibition of antigen presentation by the glycine/alanine repeat domain is not conserved in simian homologues of Epstein-Barr virus nuclear antigen 1.CTCF prevents the epigenetic drift of EBV latency promoter QpNewly emerging therapies targeting viral-related lymphomas.Epstein-Barr virus provides a survival factor to Burkitt's lymphomas.Chromatin organization of gammaherpesvirus latent genomes.Extensive co-operation between the Epstein-Barr virus EBNA3 proteins in the manipulation of host gene expression and epigenetic chromatin modification.Redefining the Epstein-Barr virus-encoded nuclear antigen EBNA-1 gene promoter and transcription initiation site in group I Burkitt lymphoma cell linesEpstein-Barr virus in Burkitt's lymphoma: a role for latent membrane protein 2AHistone acetylation and reactivation of Epstein-Barr virus from latency.Control of cell cycle entry and apoptosis in B lymphocytes infected by Epstein-Barr virus.Dendritic cells transduced with an adenovirus vector encoding Epstein-Barr virus latent membrane protein 2B: a new modality for vaccination.Enhancement of adenovirus vector entry into CD70-positive B-cell Lines by using a bispecific CD70-adenovirus fiber antibodyEstablishment of latent Epstein-Barr virus infection and stable episomal maintenance in murine B-cell lines.The Epstein-Barr virus and its association with human cancers.Epstein-Barr virus nuclear antigen 2 (EBNA2) gene deletion is consistently linked with EBNA3A, -3B, and -3C expression in Burkitt's lymphoma cells and with increased resistance to apoptosis.Gamma interferon can block herpes simplex virus type 1 reactivation from latency, even in the presence of late gene expressionThe Epstein-Barr virus R transactivator (Rta) contains a complex, potent activation domain with properties different from those of VP16.Host factors LR1 and Sp1 regulate the Fp promoter of Epstein-Barr virus.
P2860
Q21131584-1AFF36AF-D1A7-45C4-9E3B-002D7756CCEAQ24314660-6A372630-2643-44AA-A3B0-EE8A3349DAF1Q24515076-E67051F5-3572-485E-A14A-4ECAA5BC1935Q24527320-92811237-AC8B-48EA-A9FA-19CF7FF643D7Q24562912-2580E44A-CEA6-4B76-B15B-FAAD0818119CQ24564697-3835636E-56FC-4927-B6C3-1D6E8C9BA294Q24607550-E2D49672-74D0-49F2-8AE9-A670DCBF5337Q24669890-EB476BEB-CBA8-4220-BF28-AC5661E899A0Q24803420-B8B21564-061F-4D0F-9EC1-B47C131005BDQ26767186-BCF5E140-9F9E-472D-9F01-F9ADB8F01A08Q26782845-95FCB39E-93FA-4FAE-943F-10D0FDACB199Q26865827-4E5B32CD-0892-4572-A62F-5FD7E7A67E48Q27345929-6DAE89A1-1FB1-4C30-A34B-238703DA8B7CQ28480586-3531E5D2-C69D-44B6-960E-5C66897A4C5CQ28547526-597A6A8A-2C67-4BE2-AFB5-359604338D99Q30442862-F981A95A-477C-4AC5-8F32-A4D952E9032BQ30452144-57AAA9B7-CBBB-400C-8E5F-3965BF59F45FQ33374980-C92400BD-90C6-49A3-9DFD-5856A7A5EEFAQ33526302-2278F08A-3A9B-4E13-AE23-AF29AFBCA26AQ33576708-79242679-E0B3-4D7E-BFFF-5851002EFA9FQ33640115-BDF72A4D-5AB6-4577-8181-DAF903834D2AQ33640213-00FF7276-D641-41B0-A8A6-2C6FF66A2173Q33649532-11F7008A-08A1-4787-8390-57AA2C3C3FB1Q33668727-391CFFAD-8973-4E24-9858-35A7898922BCQ33699201-A9386C21-A209-4F3C-9BCD-7D6BA3772B6AQ33716529-8553F8CC-8E28-453B-B118-0AC3A03A1976Q33729584-3824503A-C119-46CF-890F-9A5E2CBA7223Q33749934-E5901B14-C4DC-466E-8377-F74EDDDB9C26Q33784685-E08407DE-BD28-4208-BA04-FE574424466CQ33794029-66F5E826-2C15-494A-B591-B796145D34ECQ33796114-93992366-FCF8-431F-844E-1E341DFE10E7Q33813615-12CA1BBB-8250-4CA1-A94D-AD41E372E394Q33825567-D78C9A89-69A0-41AD-9760-EBD8A79F15C8Q33851887-5CBE1600-A985-401E-B228-CA6AB7498262Q33866311-8872C6D0-2879-4C80-8079-F4578CF30CA0Q33882153-8FF7A3FC-D8AC-44B5-9A19-44D35938CE2DQ33911843-6172BF20-DE9A-4F3E-8671-D7CD0875B8C0Q33911947-0846A7CA-662C-4E79-81E7-77777533319FQ33936163-E2993A73-C44E-44C0-BF4F-2BA4AA548E08Q33965965-0EDDBECC-43EC-4606-8D15-BA1462D6FC25
P2860
Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma cells
description
1987 nî lūn-bûn
@nan
1987 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1987 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
name
Differences in B cell growth p ...... on in Burkitt's lymphoma cells
@ast
Differences in B cell growth p ...... on in Burkitt's lymphoma cells
@en
type
label
Differences in B cell growth p ...... on in Burkitt's lymphoma cells
@ast
Differences in B cell growth p ...... on in Burkitt's lymphoma cells
@en
prefLabel
Differences in B cell growth p ...... on in Burkitt's lymphoma cells
@ast
Differences in B cell growth p ...... on in Burkitt's lymphoma cells
@en
P2093
P2860
P1433
P1476
Differences in B cell growth p ...... on in Burkitt's lymphoma cells
@en
P2093
P2860
P304
P356
10.1002/J.1460-2075.1987.TB02568.X
P407
P577
1987-09-01T00:00:00Z